|
Çмú´ëȸ ÀÏÁ¤
09:00- µî·Ï
09:50-10:00 °³È¸»ç ȸÀå ÀÌȯÁ¾
10:00-12:00 ½ÉÆ÷Áö¿ò I.°³Á¤µÈ ¼Ò¾ÆÃ»¼Ò³â °áÇÙ Áø·áÁöħ°ú ÃÖ½ÅÁö°ß
ÁÂÀå: ÇѾçÀÇ´ë ¿À¼ºÈñ, °æÈñÀÇ´ë Â÷¼ºÈ£
10:00-10:40 Áø·áÁöħ °³Á¤ ¹è°æ ¹× Áø´Ü°ú Ä¡·á °üµ¿ÀÇ´ë ÃÖ°æ¹Î
10:40-11:20 Àẹ°áÇÙ°¨¿° Áø´Ü°ú Ä¡·á °¡Å縯ÀÇ´ë ±èÁ¾Çö
11:20-12:00 Çѱ¹ÀÇ ¼ºÀÎ °áÇÙ ÇöȲ ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø È£Èí±â³»°ú °í¿øÁß
12:00-12:30 ÃÑȸ
12:30-13:20 Áß½Ä
13:20-14:00 Ư ° I ÁÂÀå: °¡Å縯ÀÇ´ë °ÁøÇÑ
Immunogenicity and safety of new pneumococcal conjugate
vaccine in Korean infants ±èâÈÖ±³¼ö (¼øÃµÇâÀÇ´ë)
14:00-14:40 Ư ° II ÁÂÀå: ¼¿ïÀÇ´ë ÀÌȯÁ¾
Recent advances in pneumococcal disease prevention and the role
of PCV13
Dr. Lopez, Anna Lena (Scientific Affairs Director – Asia Pacific, Pfizer Inc)
14:40-15:00 Coffee Break
15:00-17:00 ½ÉÆ÷Áö¿ò II.±¹°¡°¨¿°°ü¸® »ç¾÷ ÁÂÀå: ¿¬¼¼ÀÇ´ë ±èµ¿¼ö, ÀÎÇÏÀÇ´ë È«¿µÁø
15:00-15:40 °³Á¤µÈ °¨¿°º´ °ü¸® ¹× ½Å°íÁöħ
Áúº´°ü¸®º»ºÎ Àü¿°º´°ü¸®°ú ¹ÚÇý°æ°úÀå
15:40-16:20 Ç×±ÕÁ¦³»¼º°ú º´¿ø°¨¿° »ç¾÷¼Ò°³ ¹× ½ÇÅÂ
±¹¸³º¸°Ç¿¬±¸¿ø ¾àÁ¦³»¼º°ú ÀÌ¿µ¼±°úÀå
16:20-17:00 ±¹°¡¿¹¹æÁ¢Á¾ Á¤Ã¥ÇöȲ°ú ¹ßÀü¹æÇâ
Áúº´°ü¸®º»ºÎ ¿¹¹æÁ¢Á¾°ü¸®°ú ¹è±Ù·®°úÀå
17:00-17:05 Çѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ »ç³ëÇÇÆÄ½ºÅ𸣠Çмú³í¹®»ó ¼ö¿©
ȸÀå ÀÌȯÁ¾, »ç³ëÇÇÆÄ½ºÅð¸£
17:05-17:10 Æóȸ»ç ºÎȸÀå È«¿µÁø |